Spots Global Cancer Trial Database for Open-Label Extension and Safety Study of Talazoparib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Open-Label Extension and Safety Study of Talazoparib
Official Title: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, EXTENDED TREATMENT, SAFETY STUDY IN PATIENTS TREATED WITH TALAZOPARIB
Study ID: NCT02921919
Conditions
Interventions
Study Description
Brief Summary: This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UCLA Hematology/Oncology - Alhambra, Alhambra, California, United States
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield, California, United States
UCLA Hematology/Oncology - Burbank, Burbank, California, United States
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare, Fullerton, California, United States
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles, California, United States
(IRB# 16-001189) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles, California, United States
TRIO-US Central Administration, Los Angeles, California, United States
UCLA Hematology/Oncology, Los Angeles, California, United States
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles, California, United States
UCLA Hematology/Oncology - Pasadena, Pasadena, California, United States
UCLA Hematology/Oncology - Porter Ranch, Porter Ranch, California, United States
UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, United States
UCLA Torrance Oncology, Torrance, California, United States
UCLA Hematology/Oncology - Santa Clarita, Valencia, California, United States
Orlando Health, Inc., Orlando, Florida, United States
Memorial Hospital West, Pembroke Pines, Florida, United States
IU Health Bloomington Hospital, Bloomington, Indiana, United States
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
Investigational Drug Senvices, Indianapolis, Indiana, United States
IU Health University Hospital, Indianapolis, Indiana, United States
University of Michigan Health System, Ann Arbor, Michigan, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Cross Cancer Institute, Edmonton, Alberta, Canada
Juravinski Cancer Clinic, Hamilton, Ontario, Canada
Jewish General Hospital, Montreal, Quebec, Canada
Institut Paoli-Calmettes, Marseille cedex 09, , France
Frauenklinik des Universitaetsklinikums Erlangen, Erlangen, , Germany
Magyar Honvedseg Egeszsegugyi Kozpont, Onkologiai Osztaly, Budapest, , Hungary
Orszagos Onkologiai Intezet "B" Belgyogyaszati-Onkologiai Osztaly es Klinikai Farmakologiai Osztaly, Budapest, , Hungary
Arensia Exploratory Medicine, Institutia Medico-Sanitara Publica Institutul Oncologic, Chisinau, , Moldova, Republic of
Szpital Lux Med, Warszawa, , Poland
FSBEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF, Moscow, , Russian Federation
Medical Technologies LLC, Saint-Petersburg, , Russian Federation
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Contact Details
Name: Pfizer Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
